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RESUME
Les essais de sélection facilitent les études en génétique, en biologie moléculaire et
en biologie cellulaire. Notre laboratoire a développé plusieurs essais de complémentation
de fragments protéiques (PCAs) basés sur des protéines rapportrices pour la survie, la
fluorescence, les changements colorimétriques et la luminescence. Le PCA consiste à
séparer le gène de la protéine rapportrice en deux et de les fusionner à deux gènes codant
pour des protéines d’intérêt. Les gènes de fusion sont exprimés dans une cellule hôte et
lorsque les deux protéines d’intérêt intéragissent ensemble, les fragments de la protéine
rapportrice se rapprochent et se replient afin de retrouver sa conformation native de la
protéine rapportrice. Les PCAs nous ont permis d’étudier les interactions protéine-protéine
lors d’une pertubation dans une voie métabolique, de cribler des librairies de gènes pour
identifier nouvelles interactions entre les protéines, et d’évoluer deux protéines afin
d’obtenir une meilleure interaction réciproque.
Le présent travail consistait à développer un nouvel essai de complémentation de
fragments protéiques avec la cytosine déaminase de Saccharomyces cerevisiae (yCD) pour
une sélection binaire positive et négative. La yCD, une enzyme impliquée dans la voie de
recyclage des pyrimidines, a été choisie car elle peut être utilisée comme protéine
rapportrice pour le développement d’un essai de survie cellulaire ou de mort cellulaire avec
du 5-fluorocytosine (5-fC). Le 5-FC est converti en 5-fluorouracil, un composé toxique
pour les cellules, par la yCD. Pour le développement du PCA yCD, nous avons fragmenté
la yCD en deux, à sept positions différentes, et fusionné chaque fragment à la fermeture
éclair à leucines de GCN4 (Zip). Nous avons utilisé le PCA yCD et identifié deux sites de
coupure permettant la régénération de l’activité cytosine déaminase. D’autre part, nous
avons criblé les sept variants de fragments Y [Fi] contre les sept variants de fragments 2
[F2] et avons identifié une reconstitution optimale de l’activité avec la combinaison Zip
[F1]yCD cut4 et Zip-[F2]yCD cuti. Cette combinaison contient une répétition d’un
fragment de la yCD localisée au niveau de la deuxième hélice cc Pour démontrer que ce
PCA peut être utilisé chez les cellules de mammifères, nous avons placé le PCA yCD sous
le contrôle des promoteurs des gènes de l’antigène carcino-embryonnaire (CEA) et de la
telomerase transcriptase inverse humaine (hTERT). Nous avons établi des lignées stables
de cellules HEK 293 avec ces constructions. Les lignées stables ont été testées avec 5-FC
et nous avons observé une diminution de croissance cellulaire due aux effets du PCA yCD
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et du 5-FC. Une optimisation du PCA yCD sera requise pour son utilisation dans les
cellules de mammifères.
MOTS CLÉs:
Selection positive et negative, essai de complémentation de fragments protéiques (PCA),
essai de survie, essai de mort, cytosine déaminase de Saccharornyces cerevisiae (yCD),
recyclage des pyrimidines, 5-fluorocytosine (5-fC), 5-fluorouracil (5-FU).
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ABSTRACT:
Selection assays are fundamental for molecular biology and celi biology. Our
laboratory has developed various protein-fragment complementation assays (PCAs) based
on reporter proteins that when reconstituted provide for survival, are fluorescent, or can
convert substrates to fluorescent, colored or luminescent products. PCA consists of
rationally dissecting a reporter gene into two fragments and fusing these separated
fragments to two genes of interest. The fusion genes are expressed in host ceils and when
the two proteins of interest interact with each other, the two fragments are brought into
proximity and refold to generate the reporter protein. PCAs have been used to study
protein-protein interactions, screen for unknown protein interacting partners, and engineer
optimal binding protein partners.
In this work, we developed a novel Binary Positive and Negative selection PCA,
which can increase the specificity of a selection system and be used for multiple
applications. This novel PCA utilizes the SaccÏzaromyces cerevisiae cytosine deaminase
(yCD), an enzyme involved in the pyrimidine salvage pathway, which allows selection for
celi survival, or celi death in the presence of 5-fluorocytosine (5-FC). 5-FC is a relatively
non-toxic prodrug that can be converted to a cytotoxic compound, 5-fluorouracil by yCD.
For the development of the yCD PCA, we fragmented yCD at seven different cut sites and
fused each fragment to the GCN4 leucine zipper (Zip) domain, which can form a
homodimer and bring the yCD fragments into close proximity. We tested the efficiency of
yCD PCA using the celi death assay and demonstrated yCD PCA activity for two cut sites.
In addition, we screened for yCD PCA activity by shuffling the seven variants of yCD
fragment 1 [F1] against the seven variants of fragment 2 [F2]. We found an increased yCD
PCA activity for the Zip-[Fi]yCD cut4 and Zip-[F2]yCD cuti, which contains two
fragments that overlap in the region of the a2 helix of yCD. The presence of these
overÏapping a2 helices in the yCD PCA could contribute to the stabilization of the full
length enzyme in a monomeric form resulting in an enhanced yCD PCA activity. We
developed and demonstrated both positive and negative selection assays in yeast using a
yCD PCA containing the overlapping a2 helix fragment combination that gave the best
activity. We then demonstrated a binary yCD PCA designed to specifically kill a
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population of mammalian ceils. In this assay the two complementary Zip-fragment fusions
were expressed under the control of two promoters demonstrated to be highly active in the
celi une of interest. Specifically, we cloned the Zip-[F1IyCD cut4 and Zip-[F2JyCD cuti
recombinant genes under the control of the promoters of carcinoembryonic antigen (CEA)
and human telomerase reverse transcriptase (hTERT) respectively, and generated stable
HEK 293 cell lines containing these two constructs. Using the yCD PCA and 5-FC death
selection assay, we demonstrated inhibition of celi growth of the resulting stable celi unes
compared to control ceil lines. Improvements in this death assay will be possible through
ongoing directed evolution efforts and optimization of selection conditions. Further a
survival assay for mammaiian ceils will be developed. We envisage many applications of
both the yeast and mammalian yCD PCAs including protein interaction dissection and
optimization, small molecule inhibitor screening, lineage switching in development and
cancer gene therapy efforts.
KEY WORDS:
Positive negative selection, survival assay, death assay, protein-fragment complementation
assay (PCA), protein-protein interaction, yeast cytosine deaminase (yCD), pyrimidine
salvage pathway, 5-fluorocytosine (5-FC), 5-fluorouracil (5-FU).
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CHAPTER 1: INTRODUCTION
1.1 Selection Assays
Development of selection assays bas facilitated studies in genetics, molecular biology
and biochemistry. The first molecular biology selection assay was adapted from a naturally
occurring resistance vector carrying a penicillinase gene, which allowed StaphyÏococcus
aureus to grow in media containing erythromycin (Lindbergi, Novick R, 1973). In 1977,
Bolivar et al. developed other cloning vectors, which were more stable and have other
antibiotic resistance markers for survival selection assays. Nowadays, in addition to
survival selection assays established by antibiotic resistance markers, other positive
selection assays have been developed based on auxotrophic markers (Barnes 1979;
Chevallier, Bloch et al. 1980; Grimm, Kohh et al. 1988). Negative selection systems have
also been developed based on strategies that cause ceil growth inhibition (Grimm, Kohli et
al. 198$; Yagi, Nada et al. 1993). Consequently, applications of selection assays have
shifted from simple phenotypic markers to sophisticated systems, which allow for
simultaneous selection of multiple characteristics as discussed in the following two
examples.
In some cases, combinations of multiple reporter proteins are required in order to
establish a complex selection strategy. This is seen in the strategy used for generating
targeted gene replacement (Capecchi 1994). The strategy consists of using two selection
markers [the neomycin resistance gene (neo) and the Herpes Simplex Virus type I
thymidine kinase gene (HSV1-TK)] as positive and negative selection reporter proteins.
First, ceils are selected for integrating the neor gene into their genome by a positive
selection assay using the antibiotic neomycin (G41$), which kilis cells that do not carry the
neot gene. Second, celis that integrated the disruption cassette with HSV1-TK gene at
random integration sites are killed using a prodrug, ganciclovir. After the dual selection
events, surviving ceils represent those that harbored a targeted gene replacement.
In other cases, a single reporter protein can be used for multiple selection assays. For
example, orotidine-5 ‘-monophosphate decarboxylase (OMPdecase), a reporter protein
encoded by the URA3 gene, can be used in either a positive or a negative selection assay.
The positive selection can be established in a URA3 deletion (uraY) strain of
Saccharomyces cerevisiae (S. cerevisiae), a uracil auxotroph, by complementing for the
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gene deletion with a plasmid canying the URA3 gene as a selection marker for growth in
minimal medium lacking uracil (Gerbaud, Fournier et al. 1979). In contrast, the negative
selection assay consists of killing yeast celis carrying the URA3 gene with 5-fluoroorotic
acid (5-FOA). The combination of URA3 gene and 5-FOA have been widely used in
plasmid shuffling assays and specific targeted gene replacement (Boeke, Trueheart et al.
1987).
Development of multiple selection systems is both laborious and time consuming. For
this reason, combining multiple selection strategies using an individual selection marker
protein could increase the efficiency and provide for multiple applications from one
selection system. This idea inspired us to develop a Binary Positive and Negative Selection
strategy using Protein fragment Compiementation Assay (PCA). As described beiow, PCA
involves reconstitution of a protein, often an enzyme, from complementary fragments and
this reconstitution is driven by the interaction of proteins to which the individual fragments
are fused (Figure 1). Thus, for example, it is possible to imagine a selection system for
creating stable celi unes for two genes simultaneously in which plasmids harboring the
genes also contain one of two individual PCA fragment-interacting protein fusions.
Expression of both PCA partners in cells that have incorporated the two plasmids would
then resuit in reconstitution of the PCA reporter protein activity and signaling incorporation
of the two genes of interest. Equally, each of the PCA pairs could be expressed under the
control of two different promoters that are uniquely active in a specific cell type, therefore
allowing binary lineage selection. Finally, if the PCA reporter protein could allow for
positive survival selection under one set of conditions but negative, death selection under
another set, one would have a binary and switchable PCA (Figure 2). A binary positive and
negative PCA could increase specificity for selecting a clonai population of cells or
increase specificity for killing a particular population of celis. In addition, a binary positive
and negative PCA could be used to screen for molecular characteristics of interacting
protein partners such as optimal binding or identification of binding motifs.
In the following sections, I will describe: a) why PCA is a good method for the
establishment of this Binary Positive and Negative selection strategy; b) some specific
applications of the Binary Positive and Negative PCA; c) selection of an appropriate
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Figure 1. Protein fragment Complementation Assay (PCA). Fragment 1 [F1] of the
reporter enzyme is fused to protein A and fragment 2 [F2] of the reporter protein is fused to
protein B. When protein A and protein B interact with each other, [Fi] and [F2] are
brought together and fold to reconstitute the reporter protein. A biological signal will be
detected in the form of ceil survival, fluorescence, luminescence, etc. depending on the
nature of the assay.
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No interaction
between A and B
No biological signal
-
A ami B interact
with eacli other
Biological signal: Survival
fluorescence
Luminescence
Figure 2. Binary Positive and Negative PCA. When protein A and protein B interact with
each other, the reporter fragments [Fi] and [F2] are brought together, fold to reconstitute
the reporter protein and display an outcome of the selection assay as: A) Positive Selection
PCA, where ce!! growth is observed or B) Negative Se!ection PCA, where celi death is
observed.
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A) Positive Selection PCA
B) Negative $election PCA
coloniesgrowth
death no colonies
reporter protein that can both regulate a metabolic pathway required for celi survival or
inhibit celi growth under different conditions; d) determination of a cellular system for the
selection assay; and e) approaches used for the development of the Binary Positive and
Negative PCA.
1.2 Protein fragment Complementation Assays
Our iaboratory has deveioped several Protein fragment Complementation Assays
(PCAs) for studying dynamic protein-protein interactions in the context of living ceils.
PCA consists of rationaliy dissecting a reporter protein into two fragments and generate
recombinant proteins with these separated fragments and two proteins of interest (Figure
1). Once the recombinant genes encoding for the recombinant proteins are constructed,
they are introduced into ceils where the fusion proteins are expressed. When the two
proteins of interest interact with each other, the cognate fragments are brought into
proximity and refold to generate the reporter protein. PCAs that have been developed to
the present are based on reporter proteins that generate signais in the form of survival,
fluorescence or color. The first few PCAs estabiished were designed for survivai selection.
These inciude murine Dihydrofolate Reductase Protein fragment Complementation Assay
(mDHFR PCA) (Pelletier, Campbeil-Vaiois et ai. 1998), aminoglycoside
phosphotransferase PCA, hygromycin B phosphotransferase PCA, and giycinamide
ribonucieotide transformyiase PCA (Michnick, Remy et ai. 2000). Fluorescent and
colorimetric PCAs have aiso been developed using mDHFR (Remy and Michnick 1999)
and beta-iactamase (Galameau, Primeau et al. 2002) as reporter proteins.
Some of the advantages of using PCA (Michnick 2001) are the foilowing: First, PCA
allows genes to be expressed in the relevant ceiluiar context and recombinant proteins can
appropriateiy undergo post-translational modifications. Second, PCA ailows the direct
detection of molecular interactions rather than via secondary events, such as transcriptional
activation (Fieids and Song 1989). Third, PCA allows interactions to occur in bioiogically
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relevant compartments of celis (Remy and Michnick 2001). Finally, one of the most
interesting features of PCA is that both fragments of the reporter protein do flot
spontaneously interact and fold. Fragment interaction/folding is induced only by the
interaction of the interacting protein partners resulting in a clear “ail or none, binary resuit”
(Pelletier, Campbell-Valois et al. 1998).
In addition to the above-mentioned properties of PCA, it can also be regulated from the
level of gene transcription (Zhang, Ma et al. 2004). Therefore, PCA can be regulated and
controlled at two levels: first, at the level of gene expression and second, by protein
protein interactions. When one protein fused to a reporter fragment is expressed, no PCA
signal can be detected. When both proteins, fused to respective reporter fragments, are
expressed but no interaction occurs between them, no PCA signal can be detected
(Pelletier, Campbell-Valois et al. 1998). Only when both proteins, fused to respective
reporter fragments, are expressed and both proteins interact with each other, will a PCA
signal be observed. The benefits of having two levels of regulatory points of PCA is the
reason why we chose to develop the Binary Positive and Negative Selection strategy using
PCA. Binary Positive and Negative PCA could be used for applications in positive
selection assays (similar to the survival selection assay of mDHFR PCA) or negative
selection assays (Figure 2). Negative selection PCA could also be refened to as death PCA
since it consists of killing ceils carrying interacting protein partners fused to fragments of
the reporter protein. Applications of the death PCA will be further covered in this project
since no previous death PCA lias been developed.
1.3 Applications of the Binary Positive and Negative PCA using the Death PCA
Taking advantage of the multiples regulatoiy points of the Binary Positive and Negative
PCA, various selection assays can be established. Here, we focus on some of the possible
applications of the death PCA:
First, death PCA could be used to increase specificity of killing cancer cells. Many
studies suggest that a toxic gene can be expressed under the control of a promoter of an
over expressed gene in cancer ceils in order to specifically kill the tumor celis (Nyati,
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Sreekumar et al. 2002; Song, Kim et aI. 2003). However, a promoter that is highly
expressed in cancer celis could also be expressed in other tissues of an organism. For
example, although the carcinoembryonic antigen (CEA) promoter is highly active in colon
cancer ceils, it is also highly expressed in the gastrointestinal ceils of the colon (Eades
Perner, van der Putten et al. 1994; Chan and Stanners 2004). Hurnan telornerase reverse
transcriptase (hTERT) promoter is another tissue specific promoter that is highly expressed
in tumor celis (Song, Kim et al. 2003). In normal ceils, hTERT is expressed at very low
level with the exception that it can also be expressed in leukocytes (Counter, Gupta et al.
1995) and stem ceils. We hypothesize that using death PCA and two promoters of highly
expressed genes in cancer ceils wilI further increase the specificity for targeting tumor
celis. This strategy consists of increasing the specificity of the toxic effect of suicide gene
therapy to act in tumor ceils that highly express both tumor marker genes and flot in normal
ceils that express only one of the tumor marker genes.
Second, a death PCA could be used for screening for bioactive molecules. Survival
selection strategies such as the yeast two-hybrids assay have successfully been
demonstrated as an in vivo inhibitor screening method (Licitra and Liu 1996; Kato
Stankiewicz, Hakimi et al. 2002). However rnany survival selection strategies require a
replica-plating step in order to recover clones. Replica-plating is time consurning and often
leads to false-positives. A death selection tool would eliminate this step. Thus hundreds of
thousands of molecules could be screened and only molecules with bioactive properties
will stand out since they will disrupt the death selection mechanism and cells could grow
and forrn colonies.
Finally, death PCA can be used to select for non-interacting mutants of an interacting
protein pair. For example, protein A and protein B interact with each other. However, we
would like to identify mutant forms of protein A that do not interact with protein B. In this
case, we could use mutagenesis and death PCA to screen for mutant forms of protein A that
do not bind to protein B. We could generate a library of protein A mutants and use death
PCA to screen for specific mutants. Since only non-interacting proteins fused to death
PCA fragments allow ceil growth, only ceils expressing mutant forms of protein A that do
not bind to protein B will be able to grow and form colonies. Plasmids carrying mutant
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forms of protein A can be isolated from the surviving colonies and sequencing of the
mutant forms of protein A can be done in order to identify mutations that change the
properties of protein A.
1.4 Candïdates for Death and Survival-Death PCA
Many proteins qualify to be a candidate for celi death selection assay or both survival
and death selection assay. However, small and monomeric proteins with well-known
structures are ideal candidates since they facilitate the process of developing a PCA.
Unfortunately, flot many “death” reporter proteins satisfy these conditions. Therefore we
included small dimeric proteins in our list of candidate proteins for the development of the
death PCA (Table I). There is always the possibility to engineer a small dimeric protein to
become a functional monomeric protein such as seen in the case of GFP (Campbell, Tour et
al. 2002).
In general, death reporter proteins can be categorized into two classes according to how
they activate the celi death pathways. The first class consists of cytotoxic proteins that
inhibit ceil division by directly interacting with the cellular machinery. For example,
bacterial toxin CcdB inhibits DNA gyrase (Bemard and Couturier 1992) and promotes cell
death by causing DNA lesions such as double-stranded breaks in DNA (Loris, Dao-Thi et
al. 1999). Diphtheria toxin A is another toxic protein that causes celi death by covalently
attaching ADP-ribose to the N-1 of the imidazole ring of diphthamide in eukaryotic
elongation factor 2 (EF-2) (Oppenheimer and Bodley 1981). The second class consists of
proteins that indirectly inhibit ceil division by activating a non-toxic compound to a toxic
compound. The latter are also known as cytotoxic pro-drug converting enzymes. Herpes
Simplex Virus-1 thymidine kinase (HSV1-TK), orotidine-5’-monophosphate decarboxylase
(OMPdecase) and cytosine deaminase (CD) are some examples. Only proteins from this
subset qualify for both survival and death assay and are therefore candidates for the
development of the Binary Positive and Negative PCA. Among the candidates listed in this
category, yeast cytosine deaminase (yCD) is an interesting candidate since the prodrug 5-
fluorocytosine is widely available, inexpensive, and a small amount is required to cause
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Table I: List of Death and Survival-Death PCA Candidates and Characteristics.
CcdB: Gene encoding for a toxin that inhibits bacterial DNA gyrase.
DTA: Diphtheria toxin A.
yCD: Yeast cytosine deaminase.
bCD: Bacterium cytosine deaminase.
HSV1-TK: Herpes Simplex Virus-I thymidine kinase.
URA3: Gene encoding for orotidine-5 ‘ -monophosphate decarboxylase.
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Protein Molecular Type of Mechanism Substrate Effective Ceil Type
Candidate Weight PCA of Conc. for
Inhibition Growth
Inhibition
CcdB 11KDa Death Inhibit NIA N/A Bacteria
GyraseA
DTA 55KDa Death Inhibit N/A N/A Mammalian ceil
eukaryotic
elongation
factor 2
yCD 17KDa Survival- Produce toxic 5-FC < 100 tg/m1 YCD KO yeast
Death metabolite 5- for yeast BCD KO bacterial
FU Mammalian ceil
bCD 35KDa Survival- Produce toxic 5-FC N/A YCD KO yeast
Death metabolite 5- BCD KO bacterial
FU Mammalian ceil
HSV-TK1 42KDa Survival- Produce toxic Ganciclovir > 1000 ig/m1 Bacteria
Death metabolite for yeast Yeast
P04- Mammalian ceil
Gancyclovir
URA3 29KDa Survival- Produce toxic 5-FOA > 1000 tg/m1 Yeast
Death metabolite for yeast
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cytotoxicity in yeast and mammalian celis. HSVI-TK is also an interesting candidate for
applications in mammalian celis since only 0.1 tM of the nucleoside analog, ganciclovir, is
required to induce ceil death (Black, Kokoris et al. 2001). However, more than 1000 tg/m1
is required to temporarily inhibit celi growth in yeast (Wera, Degreve et al. 1999). Since
our goal is to establish an assay that could be used in both yeast and mammalian celi
systems, we chose to develop this survival and death PCA using yCD.
1.5 Yeast Cytosine Deaminase
Cytosine deaminase (CD) is an enzyme involved in the pyrimidine salvage pathway
(Kurtz, Exinger et al. 1999) and was initially discovered in yeast and Escherichia cou (E.
cou) in 1925 by Hahn and Schafer (Hahn and Schafer 1925). CD is not present in higher
eukaryotic celis such as plant and mammalian celis (Nishiyama, Kawarnura et al. 1985).
The yeast cytosine deaminase (yCD), has been used as a reporter protein for both positive
and negative selection as discussed below (Wei and Huber 1996; Gallego, Sirand-Pugnet et
al. 1999; Xiaohui Wang, Viret et al. 2001).
a) yCD in pyrimidine salvage pathway and survival selection assay
In S. cerevisiae, yCD is encoded by the fCYJ gene. The presence of this enzyme
allows yeast to use environmental cytosine as a source of pyrimidine for the nucleotide
pooi (Figure 3) in the same way as bacteria (Grenson 1969). Cytosine enters into the celi
using a purine-cytosine transporter encoded by the FCY2 gene. In the cytosol, cytosine is
deaminated to uracil by yCD (Erbs, Exinger et al. 1997). Once cytosine is converted to
uracil, uracil can be phosphoribosylated to uridine 5’-monophosphate (UMP) by uracil
phosphoribosyltransferase (encoded by the FUR] gene) (Kern, de Montigny et al. 1990).
UMP can be further phosphorylated to become uridine 5’-triphosphate (UTP) by uridine
kinase (encoded by the URK] gene). UTP can then be converted by thymidylate synthase
(encoded by the CDC2J gene) to thymidine monophosphate (TMP). Thus, yeast possesses
a pyrimidine sauvage pathway that allows it to recycle exogenous cytosine for the ribose
and deoxyribose nucleotide pool.
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Figure 3. Pyrimidine Salvage Pathway and Survival Selection Strategy in S. cerevisiae.
When one of the key enzymes (encoded by URA2 or URA3 gene) of the pyrimidine de novo
pathway is disrupted, the ceil cannot produce uridine triphosphate (UTP). In order for the
celi to survive, it must use the pyrimidine salvage pathway to import extracellular cytosine,
deaminate cytosine to uracil by yCD (encoded by FCYJ gene), and modify uracil to UTP.
Proteins involved in this process are shown by their gene name in italics: aspartate
transcarbamylase (URA2), dihydrooratase (URA4), dihydrooratate dehydrogenase (URA I),
orotate phosphoribosyltransferase (URA5 and URAJO), orotidine-5 ‘-phosphate
decarboxylase (URA3), uridine kinase (URK1), purine-cytosine transporter (FCY2), yeast
cytosine deaminase (FCY]), uracil phosphoribosyltransferase (FUR]).
12
De Novo Pathway $aïvage Pathway
(INHIBITED)
Extracellular environrnent Cytosine FCY2
L-aspartate L-glutarnine
Cytosolic environrnent I
phosphate URA2 Cytosine
Carbamoyl-L-aspartate F120
H20 URA4
FCVI
Dihydroorotate NH3
acccptor
lIRAi
PRPP Uracilreduced acceptor
Orotate
lIRA 10 pyrophosphate
fURIPRPP lIRAS
pyrophosphate
Orotidine-5 ‘-phosphate
UMP
C02
URA3 ATP
UMP
URKI ADP
URKI
UTP
$URVIVAL
In addition to relying on the pyrimidine salvage pathway, S. cerevisiae can synthesize
ribose and deoxyribose nucleotides using the de novo pyrimidine synthesis pathway.
However, when the de novo pyrimidine synthesis pathway is inhibited, celis become uraci!
auxotrophs and thus require the essential nucleoside uracil for surviva!. Under these
conditions, the pyrimidine salvage pathway becomes the main source for generating uracil.
Therefore, yCD cari become an important regu!atory enzyme that controls ce!! growth.
This allows for the possibility of establishing a survival se!ection assay. Such a positive
selection assay lias been established in yeast (Erbs, Exinger et al. 1997) and in mammalian
cel!s (Wei and Huber 1996). In yeast, OMPdecase is one of the key enzymes in uracil
synthesis and pyrimidine de novo synthesis (Figure 3). Disruption of the URA3 gene will
force the ce!! to use yCD to convert environmental cytosine to uracil for ce!! surviva!. In
mamma!ian ceils, gene knockouts in the pyrimidine de novo synthesis pathway also force
celis to utilize the pyrimidine salvage pathway for survival. However, pyrimidine de novo
synthesis can a!so be blocked by an inhibitor known as N-(phosphonacetyl)-L-aspartate
(PALA). PALA inhibits aspartate carbamyl transferase (CADases), an enzyme in the
carbamoyl-phosphate synthetase complex (Swyryd, Seaver et al. 1974). Mamma!ian celis
treated with PALA wil! undergo apoptosis (Wei and Huber 1996) unless an exogenous
cytosine deaminase enzyme (yCD) is introduced into the celi and cytosine is added as a
supplement to the culture medium.
b) yCD Death Se!ection Assay
In addition to cata!yzing the deamination of cytosine, yCD can also deaminate 5-
methylcytosine and 5-fluorocytosine (5-FC) (Wang, Sable et a!. 1950). 5-FC was initially
synthesized in 1957 in prospective as an antitumor agent but instead was found to have
uti!ity as an anti-fungal agent (Grunberg, Titsworth et al. 1963). yCD can deaminate 5-FC,
a relative!y non-toxic compound, to 5-Fluorouraci! (5-FU), a toxic compound (Figure 3 in
brackets). 5-FU can be ribosylated to 5-fluorouridine monophosphate (5-fUMP) by uracil
phosphoribosy!transferase (FUR] gene). 5-FUMP is further phosphory!ated by uridine
kinase (URK] gene) to become 5-fluorouridine triphosphate (5-fUTP). 5-FUTP inhibits
ceil growth by incorporating into RNA (Fang, Hoskins et al. 2004; Lum, Armour et al.
2004) and directÏy inhibiting thymidy!ate synthase (CDC2] gene), an enzyme that controls
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Figure 4. Pyrimidine Salvage Pathway and 5-Fluorocytosine Death Assay in S. cerevisiae.
Enzymes involved in this process are shown by their gene name in itaÏics. Environmental
cytosine is transported into the celi by the purine-cytosine transporter (ECY2). Yeast
cytosine deaminase (FCY1) deaminates cytosine (C) to generate uracil (U). Uracil
phosphoribosyltransferase (FUR]) phosphoribosylates uracil to uridine monophosphate
(UMP). UMP is phosphorylated by uridine kinase (URKJ) to uridine diphosphate and
uridine triphosphate (UTP). UTP can incorporate into RNA and serve as a substrate for
thymidylate synthase (CDC2]) for the de novo synthesis of thymidine monophosphate
(TMP). 5-Fluorocytosine (5-FC) can also be processed by enzymes of the pyrimidine
salvage pathway and allow the establishment of a death assay. 5-FC and its derivatives are
shown in brackets. 5-FUTP is the toxic compound that causes inhibition of ceil growth. 5-
FUTP can incorporate into RNA and inhibit thymidylate synthase.
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DNA synthesis (Parker and Cheng 1990; Longley, Harkin et al. 2003). In S. cerevisiae, the
effects of yCD and 5-FC resulted in morphological changes preventing daughter ceils to
separate from the mother celis (Zhang, Zhang et al. 2002). Hence, yCD and 5-FC can be
used as a selection tool for targeting ceil death. This negative seÏection lias been suggested
for a plasmid shuffling assay by Erb et al. in 1997 and is currently being explored for
applications in gene therapy.
1.6 Selection of a cellular system for the development of the Binary Positive and
Negative PCA
The selection of the cellular system for establishing a Binary Positive and Negative
PCA is dependent on the selection of the reporter protein. The objective is to select a
system that is amenable to monitoring the signal of the PCA. Wild-type strain of S.
cerevisiae lias a gene that encodes for cytosine deaminase (yCD). However, many yCD
knockout strains of S. cerevisiae have been reported in small scale (Erbs, Exinger et al.
1997) and large scale (Giaever, Chu et al. 2002) studies. The latter large scale gene
disruption project utilized S. cerevisiae strain BY4741 (MA Ta ura3AO Ïeu2AO his3Al
metSAO) and BY4742 (MA Ta ttra3AO leu2AO his3A] lys2AO) for their gene disruption
project. Since the URA3 gene is disrupted in botli BY4741 and BY4742 strains, the
pyrimidine de novo synthesis pathway can be blocked by removing cytosine from the
culture medium. yCD knockout ceils cannot grow under these conditions. yCD becomes
the regulatory enzyme for the pyrimidine salvage pathway and can regulate ceil survival.
These yCD knockout strains of BY4741 and BY4742 can be used for the development of
our yCD PCA since botli tlie survival and deatli selection assays can be tested in tliese
strains.
1.7 Approaches for establishing the Binary Positive and Negative yCD PCA
Tlie approach for developing yCD PCA consisted of carefully analyzing the structure of
tlie protein and selecting specific sites for fragmentation. Furtliermore, in order to increase
the possibility of finding tlie best yCD fragments that can generate highest yCD PCA
activity, a fragment sliuffling experiment can be done.
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Figure 5. yCD topology. yCD monomer is composed of six alpha (a) helices and five
beta (I) strands. The first a-lieux (ai) is found at the N-terminal of the protein followed
by a f3-hairpin, (32, I3), a second a-helix (a2), a Rossmon fold (33-a3-(34-a4-f35), and
two short helices (a5-a6). The five [3-strands form a f3-sheet sandwiched between a
helices (al and a5) on one side and a-helices (a2, a3, a4, and a6) on the other side.
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a) Molecular Characteristics of yCD
The structure of yCD has recently been solved (Ireton, Black et al. 2003; Ko, Lin et al.
2003). yCD differs significantly from bacterial cytosine deaminase (bCD) in terms of
quaternary structure, primary amino acid sequence, molecular mass, and relative substrate
specificities and affinities. yCD is a homodimer where the 17.5 KDa monomers are
arranged in a 2-fold symmetry axis. The dimer is formed from the association of the two
monomers in a head-to-tail orientation. Each monomer forms a compact domain composed
of six alpha ta) helices and five beta (3) strands (Figure 5). The five -strands form a f3-
sheet sandwiched between a-helices (al and a5) on one side and a-helices (a2, a3, a4,
and a6) on the other side. There is one active site present per subunit. The active site
involves amino acid histidine-62, glutamate-64, cysteine-91, and cysteine-94. Each active
site can bind a tetrahedral catalytic zinc ion, which helps to coordinate the substrate and
participate in an acid/base catalysis mechanisrn. Amino acids histidine-62, cysteine-91 and
cysteine-94 are also involved in the coordination of the zinc molecule.
b) Fragmentation of a Reporter Protein
The fragmentation sites were chosen in regions of the enzyme flot involved in
secondary structure elements such as aipha-helices or beta-strands of the protein. Cutting
reporter proteins in loop regions connecting one secondary structure element to another is
favored. In the case that the reporter protein is an enzyme, we select for loop regions not
involved in the active site of the enzyme. Cutting within secondary structure elements
could interfere with the refolding of the reporter protein. Thus, the idea is to fragment the
reporter protein in such a way that it could easily refold to its functional structure
resembling the native protein.
c) Optimization of yCD PCA Activity by Fragments Shuffling
It lias previously been shown that two fragments of an enzyme containing overlapping
amino acid residues could rearrange to generate a functional enzyme (Taniuchi and
Anfinsen 1971; Ostermeier, Nixon et aÏ. 1999). In addition, it lias also been known that
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elimination of some residues in a peptide fragment could increase or decrease the activity
of an engineered protein (Ostermeier, Nixon et al. 1999). By shuffling yCD fragment 1
versus yCD fragment 2 of the different cut sites, different PCA combinations can be
screened in order to increase the activity of yCD PCA.
1.8 Specific aims
The goal of this project is to develop a Binary Positive and Negative PCA using yeast
cytosine deaminase (yCD PCA). In brief, this study consisted of: 1) fragmenting yCD to
generate the PCA; 2) testing yCD fragments for yCD PCA activity using the death and
survival assay as well as improving yCD PCA activity; and 3) demonstrating a possible
application of the Death PCA in a mammalian celi system.
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CHAPTER 2: MATERIALS AND METHODS
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2.1 Yeast genomic DNA, yCD knockout yeast strains, and substrates
S. cerevisiae strain BY4743 (diploid iira3AO leu2AO his3A] met5AO lvs2AO) was
used for isolation of genomic DNA containing two wild-type copies of the yCD gene. S.
cerevisiae 3Y4741 yCD knockout and BY4742 yCD knockout, generated as part cf the
yeast gene knockout collection (Giaever, Chu et al. 2002), were used for yCD PCA since
their genomic copy of yCD have been disrupted. Ail yeast strains were gifts from Dr.
Howard Bussey. YPD (yeast extract, peptone, and dextrose) and synthetic defined medium
with amino acids complementation (SDC) were prepared as described by Guthrie et al.
(Guthrie C, Fink GR 1991). YPRO62w knockout strains were propagated in medium
containing 200 1g/ml cf Geneticin® (G41$) purchased from Invitrogen (Burlington,
Ontario). 5-fC and cytosine [purchased from Sigma (Oakville, Ontario)] were diluted in
water to a concentration of 10 mg/ml and kept as stock solution.
2.2 yCD PCA development in yeast
Yeast expression vectors p4i3Gall and p4l5Gall (Mumberg, Muller et al. 1995),
used for yCD PCA development, were gifts from Dr. Howard Bussey. First, GCN4 leucine
zipper and one third of the iinker sequence coding for amine acids GGGGS was amplified
by polymerase chain reaction (PCR) with pfu polymerase, purchased from Fermentas
(Burlington, ON), from the plasmid pcDNA3.1-Zip-[Fl.2] mDHFR (Remy and Michnick
1999) using the following primers: 5’-cgc tctaga ggg
ATGAACACTGAAGCCGCCAGGCG-3’ and 5’-ccg ctcgag cta tccgga gccaccgccacc
GCGTTCGCCAACTAATTTC-3’. GCN4 leucine zipper was cloned into the multiple
cloning sites cf p4l3Gall and p4l5Gall vectors at the XbaI and XhoI restriction sites. A
unique BspEi site was added as part cf the linker sequence for cloning DNA fragements
downstream cf the GCN4 leucine zipper sequence (Figure 6). The vectors carrying these
GCN4 leucine zipper sequence are named p4l3Gall-Zip and p4l5Gall-Zip.
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Figure 6. yCD PCA construction scheme. First, the gene of interest is cloned into the
vector, for example GCN4 cou-cou leucine zipper (Zip) sequence cloned into the multiple
cloning sites with a flexible linker and BspEI of p4l3Gall or p4l5Gallvectors using the
XbaI and XhoI sites. Next, yCD or yCD fragments are cloned downstream of the Zip
sequence using BspEI and XhoI sites.
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Stepi: Insert Zip and 5 arnino acids (Saa) sequence with BspEl restriction site in
multiple cloning sites of vector using XbaI and Xhol sites.
Step2: insert 10 amino acids sequence and
yCD fragment using BspEI and XhoJ sites.
Xbal BspEI X ho!
p4.l3 Gali
or
p4i5GaIl
I
BspEI XhoI
p413 Gall/Zip
or
p4l5Gall/Zip
yCD gene and yCD fragments were amplified from S. cerevisiae strain 3Y4743
genomic DNA using pfu polymerase (Fermentas, Burlington, Ontario) with the remaïning
linker sequence codïng for amino acïds GGGGSGGGGS. Conditions used for PCR were
the following: 95°C (5 mm), 25 cycles of [95°C (1 mm), 55°C (1 mm), 72°C (1 mm)], 72°C
(3 mm). The primers used for amplifying yCD and yCD fragments are listed in Table II.
These PCR products were cloned into p4l3Gall and p4l5Gallvectors downstream of
GCN4 leucine zipper sequence using BspEI and XhoI restriction sites and T4 DNA ligase
purchased from Fermentas (Burlington, Ontario).
2.3 Yeast Ceil Transformation
Competent yeast celis were prepared and stored at —80°C (Knop, Siegers et al.
1999). In brief, MATa, MATa, and diploid yCD knockout yeast colonies were inoculated
for 6 hours in 5 ml of YPD medium with 200 ig/ml G418. These pre-cultures were used to
start a 100 ml culture for overnight incubation. The next day, when the culture reached
0D600 0.5 to 0.7, cells were harvest by centrifugation at 1500 rpm for 5 min at room
temperature (RT). The pellets were washed with 5 ml of sterile water, centrifuged for 5
min at 1500 rpm, and washed with 5 ml of Sorbitol Buffer (1 M sorbitol, 1 mM EDTA, 10
mM Tris pH 8.0, 100 mM LiOAc). Pellets were resuspended in 720 tl of Sorbitol Buffer
and 80 tl of Salmon Sperm DNA at 10 mg/ml stock solution purchased from Sigma
(OakviÏle, Ontario).
Yeast cell transformation was performed by mixing 100 ng of plasmid DNA with 25
il of frozen competent yeast celis in a 1.5 ml microtube. 150 d of PLATE solution (40%
PEG 4000, 100 mM Lithium Acetate, 10 mM Tris pH 7.5 and 0.4 mM EDTA) was added.
The sample vas mixed and allowed to incubate for 30 min at RT. 20 pi of
Dimethylsulfoxide (DMSO), purchased from Fisher Scientific (Fairlawn, NJ), was added,
and incubated at 42 °C for a 20 min heat shock. Cells were pefleted by centrifugation at
2000 rpm for 3 min. The supernatant was discarded and the pellet was resuspended in 200
tl of PLATE solution. 20 il of the sample was plated on synthetic defined medium with
amino acid complementation for selection (6-well plate) and allowed to incubate at 30 °C
for 3 days.
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2.4 Protein Expression in Yeast
Colonies were inoculated in 1 ml of synthetic defined medium (6.7 g/L of yeast
nitrogen base without ammonium sulphate and amino acids [purchased from BioshopJ), 1
g/L monosodium glutamic acid, 2 g/L amino acid drop-out lacking methionine, lysine,
histidine, or leucine, 200 ig/ml G418, and 2% raffinose (SC -met -lys -his or—leu +G418).
The cultures were grown overnight and then induced with 2% galactose for 24 hrs. Celis
were collected and prepared for protein extraction using Lyticase method (Sambrook J.
1989). The cell pellet was washed with Phosphate-Buffered Saline (PBS). The pellet was
resuspended in Stabilizing Buffer A [1 M sorbitol, 10 mM MgC12, 2 mM dithiothreitol
(DTT), 50 mM potassium phosphate pH 7.8, 100 igIml, and phenylmethylsulfonyl fluoride
(PMSF)] and incubated at 30 °C for 10 min. The sample was pelleted, resuspended in
Stabilizing Buffer 3 (1 M sorbitol, 10 mM MgC12, 2 mM DTT, 25 mM potassium
phosphate pH 7.8, 25 mM sodium succinate pH 5.5, 100 tg/ml PMSF), and incubated at 30
°C for 2 min. Then 10 d of Lyticase vas added to the sample and incubate at 30 °C for 30
min. Protoplasts were collected by centrifugation at 12 000 rpm for 10 min at 4 °C,
resuspended in 100 tl No-salt lysis buffer (50 mM HEPES pH 7.0, 1% NP-40, 1 tg/ml
aprotinin, and 100 ig/m1 PMSF), and incubated for 30 min on ice. Protein concentration
was determined using Bio-Rad DC Protein Assay [purchased from Bio-Rad (Hercules,
CA)] since 1 % NP-40 was used in the lysis buffer.
for western blot analysis, 30 tg of protein extracts were loaded per well onto a
12.5% sodium dodecyl sulfate polyacryÏamide gel electrophoresis (SDS-PAGE). After
electrophoresis, proteins from the acrylamide gels were transferred onto PVDF membranes.
The membranes were blocked with 5% milk in Tris-NaCÏ Buffer (50 mM Tris pH 7.5, 150
mM NaC1, 0.2% Tween) overnight. Membranes were probed at RT for one hour with anti
yCD purchased from Biogenesis (Poole, England) at a 1/1000 dilution and with anti-sheep
HRP purchased from Upstate ceil signaling solutions (Lake Placid, NY) at a 1/5000
dilution. Membranes were washed 3 times 10 min with Tris-NaC1 Buffer after each
antibody incubation. Membranes were revealed with Western Lightning®
Chemiluminescence Reagent Plus purchased from PerkinElmer (Boston, MA). Membranes
were stripped with stripping solution purchased from Promega (Madison, WI) and re
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blocked with 5% milk in Tris-NaC1 Buffer for 30 min at RT. Membranes were probed at
RT for one hour with anti-yeast 3-phosphoglycerate kinase (anti-PGK) purchased from
Molecular Probes (Eugene, Oregon) at a 1/1000 dilution, washed 3 times for 10 min with
Tris-NaCI Buffer, probed with anti-mouse HRPO purchased from BD Biosciences (San
Diego, CA) at a 1/5000 dilution, and revealed with Western Lightning®
Chemiluminescence Reagent Plus.
2.5 5-FC Death Assay on Liquid and Solid Medium
Yeast colonies were inoculated ovemight in 1 ml of SDC-met-lys-his-leu + G418 +
2% raffinose. The next day, 20 d cf the culture was transferred to 1 ml of SDC-met-Iys
his-leu + G418 + 2 % raffinose and 2 % galactose for a 6 hrs induction at 30°C.
For 5-FC death assay in liquid medium, either 500 or 5000 celis were transferred te
a 96-well plate with selection medium containing 0, 100 or 1000 tg/ml of 5-FC. Amount
cf ceils were determined based on optical density measurement at 600 nm (OD 600nm). OD
600nm cf 1 equals to 106 cells per ml. Samples were incubated at 30°C with shaking for 1 to
2 days. After the incubation time, 200 tl samples were transferred to a 96-well plate for
measuring OD 600nm with Spetramax 190 from Molecular Devices (Sunnyvale, CA). The
percentage of relative growth inhibition vas calculated as follows: {(OD ioo nm non-treated
celis — OD 600nm treated cells) / (OD 6nm non-treated ceils)] * 100.
For 5-FC death assay on solid medium, around 5000 ceils were transferred to 1 ml
of SDC-met-lys-his-leu + G418 + 2% raffinose and 2% galactose (with and without 5-FC)
for an 18 hrs pre-incubation at 30°C shaking. After the pre-incubation period, 10 d of the
samples were plated on solid selection medium: SDC-met-Iys-his-leu + 2% Agar + G418 +
2% raffinose and 2% galactose (with and without 5-FC). Plates were incubated at 30 °C for
either 2, 3, or 6 days.
2.6 Survival Assay on Solid Medium
Yeast colonies were inoculated ovemight in 1 ml of SDC-met-lys-his-leu + G418 +
2% raffinose. The next day, 20 tl cf the culture vas transferred to 1 ml of SDC-met-Ïys
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his-leu + G41$ + 2% raffinose and 2% galactose fora 6hrs induction at 30°C. 10 d ofthe
samples were plated solid selection medium: SDC-met-lys-his-!eu + 2% agar + G418 + 2%
raffinose and 2% galactose (with and without cytosine). Plates were incubated at 30 °C for
either 2, 3, or 6 days.
2.7 Mammalian Celi Lïnes and Reagents
Mammalian HEK293 was a gift from Dr. Guy Boileau’s laboratory. Mammalian
colon cancer ce!! unes CaCo-2 and LoVo were generously provided by Dr. C!ifford
Stanners’ laboratory. Mammalian 6, 12, 96-we!! culture plates are treated for ce!! cu!ture
and are purchased from Corning COStar (Acton, MA). Du!becco’s Modified Eag!e
Medium (DMEM), Minimum Essential Medium a!pha-Medium (a-MEM), Du!becco’s
Phosphate-Buffered Sa!ine (PBS) and Trypsin-EDTA are from Invitrogen (Burlington,
Ontario). Fetal Bovine Serum (FBS) is provided by Wisent (Saint-Jean-Baptiste de
Rouville, Quebec). Transfecting reagent Fugene 6 is from Roche Diagnosics (Basel,
Switzer!and). ZeocinlM vas purchased from Invitrogen (Bur!ington, ON)
2.8 Construction of Mammalian Celi Promoter Characterization Vectors
Primers used to amplify tissue specific promoters are !isted in Table III.
Carcinoembryonic antigen promoter ( CEAp from -407bp to —43bp), CEA enhancer (CEAe
from -6.lkb to —4kb), CC6 promoter (CC6p from -281bp to —2bp), and CC6 enhancer
(CC6e from-1.24kb to —0.585kb) were amp!ified with pfu po!ymerase (Fermentas) from
LoVo cell !ine genomic DNA using the fol!owing PCR condition: 95°C (5min), 25 cyc!es
of [95°C (imin), 62°C (lmin), 72°C (imin)], 72°C (3min). Human telomerase reverse
transcriptase prornoter (hTERTp) was amp!ified with pfu polymerase (Fermentas) from
LoVo ceil line genomic DNA using the following PCR conditions: 95°C (Smin), 25 cycles
of [95°C (lmin), 60°C (30sec), 72°C (30sec)], 72°C (3min). The PCR reaction was
supplemented with 250 ig of bovine serum a!bumin and 0.1 M of betaine both purchased
from Sigma (Oakvil!e, ON). CEAp, CC6p and hTERTp were c!oned into pGL3prom,
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Sense Primers
5’-cccggg ctcgag CCCGGGACCCTGCTGGGYFTC-3’
5’- cccggg acgcgt GGTFACATTACAAAGTGGAAT-3’
5 ‘-cccggg ctcgag CTFGCFFCTCAGAGCATCTTC-3’
5 ‘-cccggg acgcgt CACAGCAATAAACACAATGAT-3’
5’-atatat ctcgag AGTGGATTCGCGGGCACAGA-3’
Anti-sense Primers
5 ‘-cccggg aagctt GAGTI’CCAGGAACGÏT]TGTC-3’
5 ‘-gggggg ctcgag CGGCTCACTGCAACCTCTGCCTC-3
5’-cccggg aagctt GGTCTCTGCTGTCTFCTCTGT-3’
5 ‘-gggggg ctcgag TFATGTGACTCTAATTTCCTG-3’
5 ‘-atatat aagctt AGGGCTFCCCACGTGCGCAG-3’
CEAp
CEAe
CC6p
CC6e
hTERTp
Table III. Primers for amplifying tissue specific promoters from genomic DNA of LoVo colon
cancer celi une.
Promoter Name
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purchased from Promega (Madison, WI) vector by removing the original SV40promoter
with XhoI and Hindili. The new vectors are subsequently named pGL3!CEAp,
pGL3/CC6p and pGL3/hTERTp. CEAe and CC6e were cloned upstream of CEAp and
CC6p using Miul and XhoI sites generating plasmids: pGL3/CEAep and pGL3/CC6ep.
In order to generate the negative control vector, the original pGL3prom vector was
digested with XhoI and Hindiil to remove the SV4O promoter. The linearized vector was
treated with Mung Bean Nuclease [purchased from NEB (Beverley, MA)] to remove the
5’nucleotide extensions and Iigated with T4 DNA Ligase [purchased from Fermentas
(Burlington, Ontario)]. This new promoterless vector was named pGL3noProm.
pGL3/CEAp, pGL3/hTERTp, and pGL3noProm vectors were confirmed with sequencing.
2.9 Mammalian celi Promoter assay vector
2 X105 HEK 293 and CaCo2 celis were seeded in 12-well plates purchased from Corning
(Acton, MA). The following day, celis were co-transfected respectively with 1 tg of
pGL3/CEAp, pGL3/CEAep, pGL3/CC6p, pGL3/CC6ep, pGL3/hTERTp, pGL3prom, and
pGL3noProm plasmid DNA and 100 ng of pRL-CMV [purchased from Promega (Madison,
WI)] using Fugene (Roche) transfecting reagent. pRL-CMV is a plasmid that carnes the
RenilÏa luciferase gene under the Cytomegolovirus (CMV) promoter. 24 hours after the
transfection, ceils from each well of the 12-well plate were trypsinized and re-plated in 96-
well clear-bottom white plate. 48 hours after the transfection, celis from the same
transfection were assayed for firefly luciferase and Renitla luciferase activity. Firefly
luciferase activity was assayed by using Promega Bright-GloT’ Luciferase Assay kit,
purchased from Promega (Madison, WI), for quantification of firefly luciferase activity. In
brief, 100 pi of the substrate was directly added to celis in the 96-well plate and celis were
lysed. Luminescence signal was acquired for 30 sec using PACKARD FUSION
MULTIDETECTION PLATE READER purchased from PerkinElmer (Woodbridge,
Ontario). Activity of Renilla luciferase was quantified by the addition of 1 !IM of
Coelenterazine [purchased from Biotium, (Hayward, CA)] and luminescence signal was
acquired for 30 sec. Resuits of the firefly luciferase activity were normalized to resuits of
the RenilÏa luciferase activity. Each plasmid was tested in three to four different
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transfection experiments. Data from the promoter assay varied relative to differences in
transfection efficiency from each transfection. Therefore, resuits of only one transfection
experiment are represented since the overali trend of the promoter activity assay is the
same.
2.10 Mammalian Expression Vectors Construction
Mammalian expression vectors pcDNA3. 1 neo and pcDNA3. 1 zeo were purchased
from Invitrogen. These expression vectors were chosen for their antibiotic resistance
genes, which were used to generate stable cell unes. Zip-yCD, and Zip-[Fl]yCDcut4 were
amplified from yeast expression vectors (p4l3Gall series) and sub-cloned into
pcDNA3. lneo using Hindili and XbaI. Zip-yCD and Zip-[f2]yCDcut4 were amplified
from yeast expression vectors (p4l5Gall) and sub-cloned into pcDNA3.lzeo using Hindili
and XbaI. This generates the following vectors: pcDNA3.lneo/Zip-yCD,
pcDNA3. 1 neo/Zip-[Fl]yCD cut 4, pcDNA3.1 zeo/Zip-yCD, and pcDNA3. 1 zeo/Zip
[F2]yCD cut4. The GCN4 leucine sequence vas replaced by the library optimized
WinZipAl (WinA) or WinZipB 1 (Win B) leucine zipper (Pelletier, Arndt et al. 1999).
WinA has the following amino acid sequence: STTVAQLEEKVKTLRAQNYELKS
RVQRLREQVAQLAS. WinB lias the following amino acid sequence:
STSVDELQAEVDQL QDENYALKTKVAQLRKKVEKLSE. WinA was generated by
overlapping oligonucleotide fragments and PCR using oligos: f-WinA: 5’-
GGGAAGCFFACCATGTCCACCACCGTGGCCCAGCTGGAGGAAAAGGTGAA
AACCCTGAGAGCCCAGAACTACGAGCTGAAGTCC-3’ and r-WinA: 5 ‘-GCCCAG
AACTACGAGCTGAAGTCCAGAGTGCAGAGGCTGAGAGAACAAGTCGCCC
AGCTGGCCTCCGGTGGCGGTGGCTCCGGA TAG -3’. WinB was generated by
overlapping oligonucleotide fragments and PCR using oligos: f-WinB: 5’-
GGGAAGCTTACCATGTCCACCTCCGTGGACGAGCTGCAGGCCG
AGGTGGACCAGCTGCAGGACGAGAACTACGCCCTGAAGACC-3’ and r-WinB: 5’-
GACGAGAACTACGCCCTGAAGACCAAGGTGGCTCAGCTGAGAAAGAAGGTGG
AGAAGCTGTCCGAAGGTGGCGGTGGCTCCGGATAG-3’. PCR was performed at
95°C (5 mm), [95°C (1 mm), 55°C (1 mm), 72°C (1 mm)] for 25 cycles, 72°C (3 mm) with
Pfx AccuPrime from Invitrogen (Burlington, Ontario). Giving rise to the following set of
29
vectors: pcDNA3.lneo/WinA-yCD, pcDNA3.lneo/ WinA-[F1]yCD cut 4, pcDNA3.lzeo/
WinB -yCD, and pcDNA3.lzeo/WinB-{F2IyCD cut4. Ail of the above vectors were
confirmed by sequencing and have the original CMV promoters of the pcDNA3.lneo and
pcDNA3. lzeo.
In order to obtain tissue specific promoters, CEAp, and hTERTp were digested from
pGL3/CEAp and pGL3/hTERTp with MluI and Hindili restriction sites and sub-cloned
into ail previously constructed pcDNA3. lneo or pcDNA3. lzeo based vectors by removing
the CMV promoter with MluI and Hindili sites. This generated the following plasmids:
pcDNA3. lneo/CEAp/WinA-yCD, pcDNA3. 1 neo/CEAp/WinA-[F1IyCD cut 4,
pcDNA3. 1 zeo/hTERTp/WinB -yCD, and pcDNA3. 1 zeo/ hTERTp/WinB -[F21 yCD cut4.
[F2]yCD cuti was sub-cloned downstream of promoter specific vectors using BspEI
and XhoI to generate pcDNA3.lzeo/WinB-[F2]yCD cuti, and pcDNA3.lzeo/hTERTp
/WinB-[F2]yCD cuti.
2.11 Generating Stable Transfectants
2.5 X iO ceils were seeded in 12-wells plates 24 hrs prior to transfection. Cells
were transfected with 1 g of plasmid DNA. The following combinations of plasmids were
used: a) CEAp /WinA-[F1]yCD cut4 and hTERTp/WinB-[f2]yCD cut4, b) CMVp /WinA
[F1]yCD cut4 and CMVp/WinB-[F2]yCD cut4, c) hTERTp/WinA-yCD, d) CMVp/WinA
yCD, and e) pcDNA3.lneo and pcDNA3.izeo mock vectors.) pcDNA3.lneo and
pcDNA3.lzeo mock vectors. 48 hrs after transfection, celis were grown in medium
containing 400 ig/m1 of G418 and 400 pg/m1 of ZeocinTM in order to select for stable ceil
lines. Selection medium was changed every 2 days. After 7 to 21 days, stable celi unes
were trypsinized and transferred to 5 cm Petri dishes. Subsequently cells were transferred
to 10cm Petri dishes and grown in medium containing 200 pg/m1 of G418 and 200 tg!mI
of ZeocinhM. These stable celi unes were allowed to reach approximately 70% confluency
and frozen for later use.
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2.12 5-FC Assay in Mammalian Ceils and MIT Assay
1 X104 celis were seeded in 96-well plate with culture medium containing 200
ig/ml of G418 and 200 tg/m1 of ZeocinTM. After 24 hrs of incubation, the medium was
changed for medium containing 0, 100 or 1000 ig/ml 5-FC and 200 tg/m1 of G418 and
200 tgIml of ZeocinTM. Media were changed once every two days. After six days of
treatment with 5-FC, celi viability was assayed by measuring the activity of dehydrogenase
enzymes presence in metabolically active ceils using the Colorimetric (MTT) assay for celi
survival and proliferation kit purchased from Chemicon (Temecula, CA). Briefly, 10 pi of
3-(4,5-dimethylthiazol-2y1)-2,5-diphenyl tetrasodium bromide (MTT) in PBS, was added to
each well of the 96-well plate and incubated for 3 hrs at 37°C. After the incubation time,
100 pi of solubilizing solution was added to each well in order to lyse ceils and solubilize
the product. Conversion of the yellow MTT substrate to a blue product was measure at 570
nm and 630 nm (Molecular Device Spectramax 190). The quantity of blue product
produced is calculated by substracting the optical density (OD) value at 570 nm minus the
OD at 630 nm. The percentage of relative growth inhibition is calculated with the
following formula:
= [(OD57Onm6yJnm untreated - OD57Oim6OOnm 5-FC treated)/ °D57Onm6OOnrn untreated] * 100
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CHAPTER3: RESULTS
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3.1 Development of yCD PCA in Yeast
We have chosen to develop a Positive/Negative Selection PCA in yeast for mainly
two reasons. First, it is both time- and cost-efficient to use yeast for the developmental
stage of our yCD PCA since no sophisticated equipment or material are required. A simple
vector system (p4l3Gall and p4l5Gall) with auxotrophic markers (Mumberg, Muller et al.
1994) and basic transformation protocol (Knop, Siegers et al. 1999) allowed us to study the
effect of our fusion gene in yeast celis. It was not necessary to establish stable cell unes as
would have been for mammalian ceils in order to maintain stable expression of the
recombinant genes. In addition, we took advantage of the haploid/diploid life cycle of
yeast in order to introduce one fragment of our yCD PCA in MATa mating type and the
other fragment in MATa mating type and then mated the MATa and MATa to generate
diploid celis carrying the two fusion genes. The second reason vas that we hoped also to
establish a negative selection PCA in yeast for future application in screening projects. In
vivo negative selection systems have been established to screen for bioactive molecules in
bacteria and in yeast based on the concept of a reverse two hybrid assay (Licitra and Liu
1996; Horswill, Savinov et al. 2004). The yCD PCA could be used for similar applications
and provide a more direct method of signal output since yCD PCA does not involve the
transcriptional regulatory system of a reporter gene (Michnick 2004).
3.1.1 Design and Construction of yCD PCA
Topological analysis of yCD structure revealed several loop regions of the protein
that could serve as sites for fragmentation of the protein. Only one large loop region,
composed of 10 amino acid residues, located between a2-helix and 133-strand (Figure 7),
was identified from the yCD structure (Protein Data Bank file: ÏUAQ). We considered this
loop region as a good eut site for yCD fragmentation since it dissects the active site of the
enzyme, glutamine-64 (E-64), from the zinc ion-binding signature motif (C-91-X-X-C-94)
of yCD which coordinates the substrate for the deamination process. Hence, yCD
fragments generated from cuts in this region were predicted to be unlikely to possess full
enzymatic activity alone. We therefore chose four eut sites in this region (Figure 7). In
addition, we have included other loop regions for yCD fragmentation in this study. Other
eut sites were located in the 132-a2, f34-a4, and (35-a5 loop regions. In brief, the seven eut
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Figure 7. yCD cut sites for PCA development. Ail cut sites are in ioop regions of the
protein. Cut site 1 is between K-56 and G-57. Cut site 2 is between R-73 and L-74. Cut
site 3 is between G-76 and K-77. Cut site 4 is between K-77 and V-78. Cut site 5 is
between K-80 and D-$1. Cut site 6 is between N-111 and Vii2. Cut site 7 is between V
132 and D-133.
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sites were: cut site 1 (between amino acid 56-57), cut site 2 (between amino acid 73-74),
cut site 3 (between amino acid 76-77), cut site 4 (between amino acid 77-78), cut site 5
(between amino acid 80-81), cut site 6 (between amino acid 111-112), and cut site 7
(between amino acid 132-133). This enzyme is very small and almost every a-helix and 3-
strand interacts with the substrate. Fragmentation of yCD between amino acid residues that
serve to make contact with the substrate and hold it in place represents a potential ctit site
for yCD PCA since this could prevent the enzyme from catalyzing the dearnination
reaction. We avoided cutting in the middle of secondary structure of a-helices and f3-
strands since this could affect important structural elements for refolding of the enzyme.
Constructions of fusion genes, used to determine yCD PCA activity, were done in
p4l3Gall or p4l5Gall vectors and are listed in Figure 8. The fusions genes were cloned
downstream of the Gali promoter which gives a high level of expression in yeast when
yeast celis are grown in medium with galactose as an inducer and no glucose (Ronicke,
Graulich et al. 1997). fragments of yCD or full length yCD were fused at the C-terminus
of the GCN4 leucine zipper. A linker region composed of 15 or 12 amino acids
[(GGGGS)3 or (GGGGS) 2GGI was inserted between the zipper and yCD fragments or
yCD. All fusion genes presented in this work were generated with the same strategy.
3.1.2 fusion Protein Expression
Expression of the fusion proteins was verified by Western blot using polyclonal
anti-yCD antibody (Biogenesis). Detection of yeast 3-phosphoglycerate kinase (PGK), a
ubiquitously expressed protein in yeast, was used as a loading control to indicate that a
similar amount of protein had been loaded in each well of the acrylamide gel. In
comparison to the mock samples (ceÏÏs transformed with the mock p4Ï3GalÏ or p4Ï5GalÏ
vectors) most yCD-fusion proteins were detected. Zip-[F2]yCDcut7 was expressed at a
very low level (figure 9) since it could only be detected on the same western blot at a
longer exposure (data not shown). Unfortunately, the polyclonal anti-yCD antibody non
specifically detected other yeast cellular proteins (20 Kda and 24 Kda in size) in addition to
yCD. The expression of Zip-[fl]yCD cut6, Zip-[FljyCD cut7, and Zip-[F2jyCD cutl
(Figure 9) fusion proteins could not be confirmed by western blot analysis using the
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Figure 8. Recombinant genes generated from yCD or yCD fragments fused to GCN4
zipper sequence. A) yCD Fragment 1 [F1] and yCD full-length enzyme, generated from
the different cut sites, were fused to GCN4 zipper forming sequences and cloned into
p4l3Gal 1 plasmid. B) yCD Fragment 2 [F2] and yCD full-length enzyme, generated from
the different eut sites, were fused to GCN4 Zipper forming sequences and eloned into
p4l5Gal 1 plasmid.
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A) Fusion ofGCN4 Zipper with yCD and yCD Cragments
p4l3GaII/Zip-{F1]yCDcutl Zip- I[1y156
p41 3Gal ‘Zip [FI ]yCD ctit2 Zip
p41 3Gal I ‘Zip [FI ]yCD ctit3 Zip
p4l3GaIl/Zip-[FljyCDcut4 Zip
p4l3Gall/Zip-[F1]yCD cut5 Zip- I1yCDaaI[XO
p41 3Gal 1/Zip-[f1 ]yCD ctit6 Zip- [FI ]yCDaal -111
p41 3GaI I /Zip-[FI JyCD cut7 Zip- [F1]vCDaal -132
p4l3GaIlZip-yCD Zip- yCDfulI-Iength
B) Fusion ofGCN4 Zipper with yCD and yCD fragments
p4l5GalI/Zip-[F2JyCD ctitl Zip
p4l5GaII/Zip-[F2JyCD ctit2 Zip
p4l5GaII’Zip-[F2JyCD cut3 Zip
p4I5GalI/Zip-[F2JyCDcut4 Zip- 8-15
p4l5GalI/Zip-[F2JyCD cut5 Zip
p4l5GalI/Zip-[F2]yCD ctit6 Zip
p4I5Gall/Zip-[F2JyCD ctit7 ZP
p4lSGall Zip yCD Zip yCD full Jength I
Figure 9. yCD PCA expression detection normalized to PGK expression. A) Zip
[F1]yCD (lane 1 to 7), Zip-yCD full-length enzyme (lane 8), and mock vector (lane 9) are
probed with anti-yCD antibody. The membrane is then reprobed for anti-PGK as a loading
control. B) Zip-[F2JyCD (lane 1 to 7), Zip-yCD full-length enzyme (lane 8), and mock
vector (lane 9) are probed with anti-yCD antibody. The membrane is then reprobed for
anti-PGK as a loading control.
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polyclonal anti-yCD antibody since their expected molecular weights are approximately the
same as the nonspecific bands however, activity of yCD PCA involving these three fusion
proteins could be detected (see section 3.2), suggesting that they were expressed.
3.1.3 yCD PCA Activity in Liquid Medium
To assay for yCD PCA activity, we performed a death assay in liquid medium to
provide a quantitative comparison of the activity of yCD PCA generated from different cut
sites to that of full length yCD. As mentioned in the introduction, the yCD knockout yeast
cannot deaminate 5-FC, a relatively non-toxic prodrug, to 5-FU, a toxic anti-metabolite,
and are therefore resistant to high concentration of 5-FC (102 M) (Erbs, Exinger et al.
1997). Thus, the yCD PCA activity could be determined as a function of reconstituted
yCD activity, which could couvert 5-FC to 5-FU, resulting in inhibition of ceil growth.
The death assay consisted of measuring the percent cell growth inhibition of yeast in the
presence of 100 pg/m1 5-fC (aproximately 1OE4 M 5-FC). This concentration of 5-FC was
determined to inhibit the growth of celis carrying a wild type copy of FCY] gene (data not
shown). Only ceils with yCD full length or reconstituted yCD fragments were sensitive to
the toxic effect of the prodrug 5-FC. Two different culture conditions have been tested in
this experiment, using different amounts of celis (Figure 10). According to both culture
conditions, the activity of yCD PCA, determined as 5-FC sensitivity, vas found for the cut
site 3 and 4. Cut site 4 (between K-77/V-78) seemed to show higher activity than cut site 3
(between G-76/K-77) under both conditions. Cells transformed with Zip-yCD full-length
constructs were highly sensitive to 100 g/ml 5-FC whereas cells transformed with mock
vectors were relatively non-sensitive to 100 tg/ml 5-FC.
3.1.4 Death Assay on Solid Media Using yCD PCA at Cut Site 4
Selection on solid medium is an important method for isolation of clones in
screening projects. A population of different cells from a liquid culture can be selected by
pÏating on solid selection medium in order to obtain individual clones. The clones could
later be expanded to clonal populations. It was therefore important for us to determine
selection conditions on solid medium. Initially, we directly plated yeast celis carrying yCD
PCA on 5-FC selection plates however; this method of selection was not very efficient for
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Figure 10. yCD PCA activity as measured by sensitivity to 5-FC in liquid medium.
Diploid celis carrying Zip-[FÏ]yCD and Zip-[f2]yCD generated from eut site Y to eut site
7, Zip-yCD full-length enzyme and mock empty vectors were assayed for yCD PCA
activity in SDC-met-lys-his-leu +2% Raffinose + 2% Galactose + 200 tg/m1 ofG4Ï8 and
100 g/m1 of 5-FC. Two different growth conditions were assayed. • 5 X io celis were
transferred to 250d of selection medium and 0D600 was taken after 24 hrs incubation. 5
X 102 celis were transfened to 250 i1 of selection medium and 0D600 was taken after 24 hrs
incubation. The relative percentage ceil growth inhibition was calculated by comparing
ceils treated and untreated with 100 ig /ml of 5-FC.
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Figure 11. yCD PCA and 5-FC sensitivity on solid media (using fragments of eut site 4).
Samples were pre-incubated for 18 hrs with 0, 30, or 100 ig/m1 5-FC in liquid selection
medium. After pre-incubation time, 10 d of each sample were plated on solid selection
medium containing 0, 100 and 1000 g/m1 of 5-FC. Each Petri dish is subdivided into four
quadrants and different samples were plated in eaeh quadrant (quadrant A: Ras-[F1]yCD
cut4 +Zip-[F2]yCD cut4, quadrant B: Zip-[F1]yCD cut4 + Zip-[F2]yCD eut4, quadrant C:
p4l3Gall + p4l5Gall moek vectors, quadrant D: Zip-yCD).
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the death selection assay since celis carrying Zip-[FYJyCD cut4 and Zip-{F2IyCD cut4
could stiil grow (data shown as control samples in Figure 11 top row). Subsequently, we
attempted to optimize the selection conditions for yCD PCA on solid media by pre
incubating celis with various amount of 5-FC in order to increase the selection stringency.
Samples were pre-incubated for 18 hrs with 0, 30, or 100 ig/m1 5-FC in liquid selection
medium and plated on solid selection medium containing 0, 100 or 1000 tg/ml of 5-FC
(Figure 11).
With no prior pre-incubation in 5-FC, ceils carrying Zip-yCD fusion protein
(displayed in quadrant D of each Petri) did not grow on medium containing 100 and 1000
ig/m1 of 5-FC. Ceils carrying Zip-[f1]yCD cut4 and Zip-[F2jyCD cut4 (quadrant B)
showed significantly reduced growth on 1000 tg/mi of 5-FC plate in comparison to the
following negative controls: ceils carrying non-interacting protein pair, Ras-[F1]yCD cut4
and Zip-[F2]yCD cut4 (quadrant A) and mock vectors (quadrant C). Ceils carrying mock
vectors (quadrant C) and non-interacting protein pair (quadrant A) grew on ail selection
plates although less colonies were observed on 1000 tg/m1 of 5-FC plate due to the general
toxicity effect of 5-FC when used at such a high concentration.
With prior pre-incubation in 30 or 100 tg/m1 of 5-FC, cells carrying Zip-yCD
fusion protein could flot form colonies when plated on medium containing 0, 100, or 1000
1gIml 5-FC. Celis carrying the Zip-[F1]yCD cut4 and Zip-[F2]yCD cut4 showed reduced
growth on 100 and 1000 g/ml of 5-FC plate in comparison to the non-interacting proteins
and mock control. An 18 hrs pre-incubation with 100 tg/rnl of 5-FC and plating on solid
medium containing 1000 g/mi of 5-FC seemed to give best results for inhibiting growth of
cells carrying the GCN4 zipper homodimer fused to yCD fragments.
3.2 Optimizing yCD PCA
PCA, carrying overlapping amino acid residues of the reporter, have been found to
generate an increase in PCA activity (Wehrman, Kleaveland et al. 20Q2). Since yCD lias
been fragmented at seven cut sites for determining yCD PCA activity, shuffling different
fragment 1 versus fragment 2 can generate yCD PCA with overlapping sequences. Testing
41
for the PCA activity of these combinations can be a simple strategy to screen for a new
yCD PCA that have better PCA activity.
3.2.1 Fragment Swappïng of yCD PCA Activity in Liguid Medium
We attempted to increase yCD PCA activity by combining fragment one of yCD
([F1]yCD) of the seven different cut sites with fragment two of yCD ([f2JyCD) of the
seven different cut sites. For example, we mated each MATa expressing Zip-[Fi]yCD cuti
with seven MATa expressing different Zip-[F2]yCD cuti through cut 7 (Figure 12 A).
This process was then repeated for [f i]yCD of the other six remaining cut sites. We tested
ail 49 different combinations and have found more yCD PCA actÏvity in other
[f 1]yCD/[F2]yCD combinations (Figure 12 B) than the original findings determined for
cut site 3 and 4 (figure 10). There were other combinations of yCD PCA (marked with +
or ++ in Figure 12 B) that gave some yCD PCA activity however; they were equal to
(noted as ++) or less than (noted as +) the original yCD PCA activity at cut site 4. AH yCD
PCA containing two overiapping a2 helices (figure 7) gave higher yCD PCA activity in
terms of sensitivity in the 5-fC death assay. The presence of these a2 helices could
stabilize the fuli-length enzyme in a monomeric form and thus enhance yCD PCA activity.
Expianation of this observation is further presented in the Discussion Section.
3.2.2 Comparison of yCD PCA Activity on Solid Media
Selection on solid medium is important for isolation of clones since we would like
to use this PCA for screening genetic library of bioactive molecules using cyclic peptides
(Scott, Abel-Santos et al. 1999). We tested various conditions for solid media selection
with 5-FC pre-incubation (Figure 13). Selection conditions with an 1$ hrs pre-incubation
with 100 g/mi 5-fC and plating on seiection plates containing 1000 ig/ml 5-fC seems to
give good resuits. The negative control (diploid celis carrying Ras-[F1}yCD eut 4 and Zip
[f2]yCD eut 4 piated on quadrant A) and the mock controi (diploid cells carrying
p4l3Gall and p4l5Gall plated on quadrant C) grew on solid medium selection containing
1000 ig/rn1 5-FC compared to ceils containing Zip-[F1ÏyCD cut4 and Zip-[f2lyCD cut4
which grew very iittle or celis carrying Zip-yCD full length which did not grow at ail. Ras
[F1]yCD eut 4 and Zip-[f2]yCD ctit 4 were used as negative control since Ras does flot
interact with GCN4 leucine zipper.
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Figure 12. Fragment swapping matrix of yCD-PCA activity in liquid medium. A) MATa
celis carryïng Zip-[F1]yCD cuti were mated with MATa ceils carrying Zip-[F2]yCD of
different cut sites (cuti to cut7). This process was repeated with MATa celis carrying Zip
[F1]yCD cut 2 to Zip-[F1]yCD cut7. B) 5 X i03 celis were assayed for their sensitivity to
100 iglml 5-FC and 0D690 was taken after 24 hrs of incubation. Resuits are qualitatively
represented on the matrix: +++, highest yCD PCA activity; ++, moderate yCD PCA
activity; +, 10w yCD PCA activity.
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Figure 13. Comparison of yCD PCA activity using 5-PC sensitivity assay on solid
selection media. Samples were pre-incubated for 1$ lirs with 100 tg/mI 5-FC in liquid
selection medium. After pre-incubation time, 10 d of each sample was plated on solid
selection medium containing 0, 100 or 1000 tg!m1 of 5-fC.
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Using the same selection condition, we had compared the activity of yCD PCA at
cut site 4 (Zip-[Fi]yCD cut4 and Zip-[F2]yCD cut4) with yCD PCA at cut site 1 (Zip -
[F1]yCD cuti and Zip-[F2JyCD cuti), and yCD PCA containing overlapping a2 helices
(Zip-{F1]yCD cut4 and Zip-[F2jyCD cuti) on solid selection medium. Since the
overlapping a2 helices yCD PCA seems to work better in liquid assay, we suspected that
yCD PCA with overlapping a2 helices could also work better than the other combinations
on solid medium selection as well. Results from the solid medium selection showed that
ceils canying Zip-[Fi]yCD cut4 and Zip-[F2]yCD cuti did flot grow with 100 or 1000
tg/m1 5-FC (Figure 13e). Ceil carrying Zip-[F1]yCD cut4 and Zip-{F2]yCD cut4 showed
significantly reduced growth however, some colonies can stiil be observed on selection
medium containing 1000 ig/m1 5-FC (Figure 13d). Ceils carrying Zip-[Fl]yCD cut 1 and
Zip-[F2]yCD cuti (Figure 13a), found to have low yCD PCA activity when tested using the
liquid selection assay (Figure 10), did flot show reduced growth on solid medium
supplemented with high 5-FC concentration (1000 pg/ml 5-FC). Celis carrying Zip
[f 1]yCD eut 1 and Zip-[f2]yCD eut4, in whieh 21 amino aeids of yCD were absent, were
also non-sensitive to 5-FC (Figure 13h). The controls of this experiment were ceils
carrying Zip-yCD full-length and empty vectors. As expeeted, celis carrying Zip-yCD full
length were sensitive to 5-FC (Figure 13e). Cells did flot grow when plated on medium
without 5-FC due to the fact that they were pre-incubated with 5-FC for 18 hrs. This resuit
is consistent with resuits observed when determining solid medium selection conditions for
yCD PCA (Figure li). Celis carrying mock vectors were resistant to high concentration of
5-fC.
In addition, we tested the overlapping a2 helices yCD PCA using another
interacting protein partners rather than the interacting homodimeric GCN4 Zipper. We
chose Ras and Ras Binding Domain of Raf-1 (RBD) as the interacting partners. The
interaction of Ras and RBD has been detected using the mDHFR (Pelletier, Campbell
Valois et al. 1998) and beta-lactamase PCA (Pelletier, Campbell-Valois et al. 1998). Ras
was fused to fragment 1 of yCD and RBD vas fused to fragment 2 of yCD (Ras-[F1]yCD
cut4 and RBD-[F2]yCD cuti). Ceils carrying these recombinant proteins were plated on
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the solid selection medium. Although flot ail celis were killed, a difference in cet! growth
inhibition can be observed (Figure 13g) in comparison to the negative control, celis
carrying Ras-[F1]yCD cut4 and Zip-[F2]yCD cuti, which were non-sensitive to 5-FC
(Figure 13h). We have also tested Ras-[F1]yCD cut4 and RBD-[F2]yCD cut4, which did
flot contain the overiapping a2 helices. However, celis were flot sensitive to 5-FC (data flot
shown).
3.2.3 Alternative Survival Assay on Solid Media
yCD PCA activity can be selected using a survival assay in a yeast strain in which
the pyrimidine de ,zovo pathway is disrupted (eg. URA3 gene deletion strain) and uracil is
absent in the culture medium. Under such conditions, only ceils that can deaminate
cytosine to uracil using yCD can grow. We tested yCD PCA using this cytosine survival
assay and found that celis transformed with yCD PCA (Zip-[F1]yCD cut4 and Zip
[F2JyCD cuti) and Zip-yCD grew after three days of incubation at 30°C with cytosine
supplementation of 1000 tg/m1 and 100 g/ml respectively (Figure 14A). No colonies
were observed for yCD PCA Zip-[Fi]yCD cut4 and Zip-{F2]yCD cut4 (Figure 14A (b)) or
any of the negative controïs: Ras-[fi]yCD cut4 and Zip-[FYJyCD cut4, Ras-[FÏ]yCD cut4
and Zip-[Fi]yCD cuti) (data not shown). When the selection assay was prolonged to six
days incubation time, colonies were detected for yCD PCA (Zip-[F1]yCD cut4 and Zip
[F2]yCD cut4) with 1000 ig/m1 cytosine supplementation (Figure 14B (b)) and colonies
were observed for yCD PCA Zip-{F1JyCD cut4 and Zip-[F2]yCD cuti with 100 tg/mI
cytosine supplementation.
3.3 Application of yCD PCA in cancer gene therapy
Previous studies have shown that yCD can be used in combination with tissue
specific promoters and 5-FC to specifically ablate tumor celis (Nyati, Sreekumar et al.
2002; Song, Kim et al. 2003). yCD PCA can also be used as a death assay to kiil a
population of celis by converting 5-FC to 5-FU. We applied this death assay under the
expression of two tissue specific promoters in order to specifically drive the expression of
yCD PCA and kili cancer celis when treated with 5-FC. Using yCD PCA under the control
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Figure 14. yCD PCA activity using the survival assay on soÏid selection media. Celis were
grown overnight in 2% Raffinose and induced for 6 hrs in 2% Raffinase + 2% Galactose.
After the induction time, 10 d of celis were plated on selection medium that does not
contain uracil but is supplemented with 0, 100 or 1000 ig/m1 of cytosine. A) Pictures were
taken after 3 days of incubation at 30°C. B) Pictures were taken after 6 days of incubation
at 30°C.
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of two tissue specific promoters could further increase the specificity of targeting the
yCD/5-FC deamination process to tumor celis.
3.3.1 Re-Characterization of Tissue Specific Promoters
We re-characterized tissue specific promoters previously described by other groups
(Hauck and Stanners 1995; Koops, Thompson et al. 199$; Nyati, Sreekumar et al. 2002).
We PCR amplified promoter sequences of CEA, CC6 and hTERT genes from genomic
DNA of LoVo ceils and subcloned them upstream of the luciferase gene in the pGL3 vector
in order to verify if the PCR products have promoter activity. In total, we generated five
vectors containing the following promoter regions: CEA promoter from -407 to —43 bp
(CEAp), CEA promoter-enhancer from -6.1 to —4 kb and -407 to —43 bp (CEAep), CC6
promoter from -281 to —2 bp (CC6p), CC6 promoter-enhancer from -1.24 to —0.585 kb and
-2$ 1 to —2 bp, and hTERT promoter from —204 to +56bp (hTERTp).
We compared the five promoters to the SV4O promoter in tumor and non-tumor cell
unes by transient transfection. Ail promoter activity using firefly luciferase as a reporter
protein were normalized to results of the Re,ziÏla luciferase activity under the CMV
promoter. Four human colon cancer ceil unes were used in this study: CaCo2, LoVo,
LS18O, and 5W1222. In addition, we tested the promoters in human embryonic kidney
(HEK 293) cells since HEK 293 cells are easy to maintain in culture and transfect.
Moreover, HEK 293 ceils can serve as a positive control for hTERTp since the hTERTp
has been known to be highly expressed in these cells (Ritz, Kuhie et al. 2005). We used a
fibroblast cell une as a negative control for the promoter study since CEA and CC6 were
previously characterized to be expressed at a very low levels in fibroblast tissue (Eades
Perner, van der Putten et al. 1994; Chan and Stanners 2004). We attempted to use human
fibroblast, MG-63 cells, in order to generate a doser comparison with the other human cell
unes. However, the transfection efficiency of MG-63 celis using Fugene, Lipofectamine,
or electroporation was very low (data not shown). Instead, the monkey fibroblast Cos-1
ceil line was used as negative control since Cos-1 cells can easily be transfected.
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Figure 15. Comparison of tissue specific promoters activity in various celi unes using a
transcriptional reporter assay. Previously characterized promoter sequence of CEA, CC6,
and hTERT were amplified from genomic DNA of LoVo ceils and sub-cloned into pGL3
vector. The plasmids were co-transfected with pRL-CMV into different ceil unes and
assayed for firefly and Renitla luciferase activity. Each panel displays normalized resuits
of promoter activity in a particular cet I une: A) HEK 293 cells, B) Cos- 1 cells, C) CaCo-2
ceils, D) LoVo celis, E) LS-18O celis, and F) SW1222 ceils. Promoter Activity is
expressed in Relative Luminescence Units (RLU).
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We found that the activity of CEA, CC6, and hTERT promoters or promoter-enhancer
sequences was not very active in monkey fibroblast Cos-1 celis (Figure 15 B) in
comparison to the SV40 promoter. In contrast, these promoters were more active in HEK
293 celis (Figure 15 A). In general, the hTERT promoter was as active or up to thirty-three
fold as active as the SV4O promoter in colon cancer celi unes (Figure 15). CEA and CC6
promoters were active at similar levels as SV40 promoter in CaCo-2 celis. We did not find
a higher activity of CEA promoter-enhancer sequence as reported by Lawrence et al., 2002.
There was also a slight increase in the promoter activity of CC6 promoter-enhancer when
compared to CC6 promoter alone in colon cancer ceil unes. From this promoter
characterization experiment, we confirmed that the hTERT promoter sequence, isolated
from genomic DNA of LoVo ceils, can drive the expression of the luciferase gene to
similar or higher expression levels as the SV4O viral promoter. These observations were
consistent with previous promoter assay results (Hauck and Stanners 1995; Koops,
Thompson et al. 199$; Song, Kim et al. 2003). In addition, since the CEA promoter has
previously been reported to be highly active in cancer cell lines (Hauck and Stanners 1995;
Koops, Thompson et al. 199$) and we have also found that it is highly expressed in CaCo-2
celis (Figure 15 C), we will use the hTERT and CEA promoter to drive the expression of
two interacting protein partners fused to yCD fragments and target these cells for
destruction using yCD PCA and 5-FC.
3.3.2 yCD PCA in Cancer Celi Lines
The general idea of using yCD PCA under tissue specific promoter is to specifically
kili cancer celis which express both CEA and hTERT tumor marker genes, while sparing
normal ceils that may express only one of the two genes. We used tissue specific
promoters of CEA and hTERT (Figure 15) to drive the expression of yCD PCA. In
addition, in order to potentially further increase yCD PCA activity, we used WinZipAl
(WinA) and WinZipBl (WinB) leucine zippers instead of the yeast GCN4 leucine zipper.
WinA and WinB have been shown to heterodimerize with a dissociation constant of
approximately 24 nM (Arndt, Pelletier et al. 2000) in comparison to GCN4 leucine zipper
domain, which forms homodimers.
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We fused WinA-[F1]yCD cut4 downstream of CEA and CMV promoters, WinB
[F2]yCD downstream of hTERT and CMV promoters, and WinA-yCD downstream of
hTERT and CMV promoters. We used these vectors to estabiish stable celi unes of CaCo2
cells, a human colon cancer cell line, since the transfection efficiency was higher than other
colon cancer ceil unes (general observation from luciferase assay in Figure 15). In
addition, we established stable HEK 293 ceIl unes since their transfection efficiency was
also high and CEA and hTERT promoters were determined to be highly active.
In brief, we have generated or are in the process of generating the following stable
cell lines in CaCo2 and HEK 293 cells (Table IV) and have tested some stable cell lines for
their sensitivity to 5-FC. Since not ail of the stable cell lines have been generated in the
CaCo-2 colon cancer cell lines, we did not include resuits from the CaCo-2 stable ceil lines
in this thesis. The stable HEK 293 celi lines were tested by incubation in medium with and
without 5-FC for 6 days. Since mammalian celis do not express cytosine deaminase, they
are relatively non-sensitive to 5-FC. A final concentration of 1000 tg/ml 5-fC was used
to study the effect of 5-FC (Figure 16). After the 6 days incubation, cell survival was
quantitatively evaluated using the MTT assay, which measures the activity of
dehydrogenase enzymes presence in metabolically active cells. Results are represented in
percentage celi growth inhibition since cells carrying yCD or yCD PCA become sensitive
to 5-FC, arrest their growth and undergo apoptosis (Fischer, Steffens et al. 2005).
Approximately 20% cell growth inhibition was observed in HEK 293 stable transfectants
canying pcDNA3.l neo and pcDNA3.lzeo mock vectors. Under the CMV promoter, HEK
293 stable cell lines canying WinA and WinB fused to yCD PCA at cut site 4, had a 30.5
inhibition % of celi growth when treated with 1000 pg/ml of 5-FC. WinA and WinB fused
to yCD PCA with the overlapping a2 helices showed about 36% cell growth inhibition.
The negative controis, ceils stably transfected with either WinA-[f1]yCD cut4 or WinB
[F2]yCD cuti showed sensitivity that is below the mock controls. Celis carrying WinA
yCD showed approximately 48.9 % of celi growth inhibition.
Under CEA and hTERT tissue specific promoters, HEK 293 stable cell lines
carrying WinA and WinB fused to yCD PCA at cut site 4, had 21 % of cell growth
52
inhibition when treated with 1000 tg/m1 of 5-FC, which is approximately equivalent to the
mock control. Therefore, no significant yCD PCA activity is observed for this cut site.
WinA and WinB fused to yCD PCA with the overlapping a2 helices showed about 30.5%
celi growth inhibition and negative controls, ceils stably transfected with either WinA
[F1]yCD cut4 or WinB-[F2]yCD cuti, showed sensitivity that is below the mock controls.
Celis carrying WinA-yCD under the CEA promoter showed around 37.8 % of celi growth
inhibition.
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Figure 16. yCD PCA activity in HEK 293 mammalian ceils stable transfected with
plasmids under CMV and tissue specific promoters expressing: WinA-[Fl]yCD cut4 and
WinB-[F2]yCD cut4, WinA-{f1]yCD cut4 and WinB-[F2jyCD cuti, WinA-[FÏ]yCD cut4
alone, WinB-[F2]yCD cuti alone, WinA-yCD, and empty vectors. yCD PCA activity is
expressed in relative % celi growth inhibition by comparing ceils treated and untreated with
1000 ig/m1 of 5-PC.
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CHAPTER4: DISCUSSION
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4.1 Binary Positive and Negative yCD PCA
In this work, we established a new Binary Positive and Negative yCD PCA, which
can be used for survival or death selection. Two factors permitted the dual selection
strategies associated with this PCA. First, the death assay is possible because of the
specific activity of yCD for catalyzing the deamination of 5-FC, a relatively non-toxic pro
drug to 5-FU, a toxic anti-metabolite, that can cause celi death (Zhang, Zhang et al. 2002;
Fiseher, Steffens et al. 2005). Second, the survival assay is achieved by genetically
inactivating the yeast pyrimidine de novo synthesis pathway in order for yCD to become
the essential regulatory enzyme in the ceil. We focused on the negative selection aspect of
this PCA since until now, no death PCA has been developed.
4.2 yCD PCA Activity
yCD is a relatively small enzyme of 17 KDa and the topology of the enzyme does
flot show many extended loop regions. We have fragmented the yCD enzyme in two
fragments at seven different cut sites and fused each fragment to GCN4 leucine zipper
domain. We established our assay to screen for restoration of yCD activity induced by
GCN4 dimerization and yCD complementation using the 5-FC death assay and cytosine
survival assay. From the seven cut sites, we found that yCD can be fragmented at two cut
sites and yCD activity can be restored by protein complementation when fused to GCN4
zipper (Figure 10). Two cut sites (eut site 3 and 4), which generated yCD PCA activity,
were located in a loop region between a2-helix and f33-strand (Figure 7). Cut site 2 and cut
site 5, also found in the same loop region as cut site 3 and 4, were observed to have no yCD
PCA activity (Figure 10). Perhaps, residues 76-77-78 (of cut sites 3 and 4) are further
extended from the enzyme’s active site whereas residues 73-74 (of eut site 2) and residues
80-8 1 (of eut site 5) are packed doser to the enzyme’s active site. It is also interesting to
note that no yCD PCA aetivity was found for eut site 6 and eut site 7. Fragment 2 of eut
site 7 corresponds to helix 5 and helix 6 of yCD and has been proposed to play an
important role in stabilizing the substrate for catalysis (Ireton, Black et al. 2003). This
eould explain why Fragment 1 (amino acid 1 to 132) of eut site 7 alone is flot suffieient to
restore yCD aetivity. In brief, yCD PCA fragmented at eut site 4 gives a better activity
than yCD PCA fragmented at eut site 3. When 5000 eells were assayed for their relative
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percentage growth inhibition (Figure 10), celis carrying yCD PCA at cut site 4 were
approximately 50% inhibited of whereas celis carrying yCD PCA cut site 3 were
approximately 30% inhibited. For this reason, further characterization of yCD PCA was
performed using cut site 4.
4.3 Overlapping Fragment yCD PCA
Many previous studies have reported that overlapping peptide sequences can
contribute to the folding of complementary enzyme fragments and to increase enzyme
activity (Ostermeier, Nixon et al. 1999; Wehrman, Kleaveland et al. 2002). In addition,
some studies also indicate that an increase of enzymatic activity can be observed from
library-generated fragment complementation by removal of some residues from the full
Iength sequence (Ostermeier, Nixon et al. 1999). We fragmented yCD at seven different
cut sites and fused each fragment to GCN4 zipper. We then transformed the constructs
containing the fragment 1 in the MATa haploïd strain and constructs containing the
fragment 2 in the MATa strain. We subsequently combined each fragment 1 with each
fragment 2 by mating the corresponding MATa and MATa clones in order to determine if a
certain fragment 1 and fragment 2 combination could resulted in increased yCD PCA
activity (Figure 11). From this experiment, we found that GCN4 zipper fused to fragment
1 of cut site 2, 3, and 4 paired with GCN4 zipper fused to fragment 2 of cut site 1, gave
better activity than the previously determined GCN4 zipper fused to fragment 1 and
fragment 2 at cut site 4 (Figure 11 B). A common element, found in these three new yCD
PCA combinations, is a sequence containing two overlapping a2 helices (Figure 7). The
combination of Zip-[Fl]yCD cut4 and Zip-[F2]yCD cuti, was further characterized and
found to have an increased yCD PCA activity determined by both survival and death assay
in comparison to Zip-[F1]yCD cut4 and Zip-[F2]yCD cut4.
yCD was purified by gel filtration (Yergatian, Lee et al. 1977) and crystallized
(Ireton, Black et al. 2003; Ko, Lin et al. 2003) as a homodimer. It is possible that the
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Figure 17. Structure of yCD. Two yCD monomers (one in blue and one in cyan) form a
homodimer associated in a head-to-tail manner. The amino terminal (N-terminal) is at the
opposite side of the dimer interface. The carboxyl terminal (C-terminal) faces the
dimerizing interface. Residues 57 to 77 from the overlapping a2 helices yCD PCA are
colored in red and are part of the dimer interface.
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dimeric configuration of this enzyme represents the active form of the enzyme. If this
hypothesis is true, then having a repetition of two a2 helices could mimic and stabilize the
dimeric form of yCD. Analysis of the yCD crystal structure shows that these overlapping
a2 helices are involved in the dimer interface (Figure 17). However, these two hypotheses
need to be tested. At the moment, we do flot know how this overlapping helix can
contribute to the increase in yCD PCA activity. We could introduce mutations that disrupt
the dimerization interface of yCD, converting it to a monomeric enzyme, and assay for
yCD activity. This experiment will reveal if the dimerization of yCD is required in order
for the enzyme to deaminate its substrate. Mutations in the overlapping a2 helices can also
be done in order to prevent each a2 helix from interacting with each other. The mutant
form of yCD PCA containing the non-overlapping a2 helices can be tested for yCD PCA
activity using the death assay.
4.4 Enhanced yCD PCA activity in Yeast
We have established a solid selection condition with yCD PCA at cut site 4 and
found that fragmentation at this site generated significantly decrease in colony numbers
after 18 hrs pre-incubation with 100 ig/m1 of 5-FC and plating on solid selection medium
(Figure 11). Using these conditions for the death assay on solid medium, we compared
yCD PCA at cut site 4 and yCD PCA with overlapping a2 helices (Zip-[F1]yCD cut4 and
Zip-[F2]yCD cuti) and found that yCD PCA with overlapping a2 helices generated a
better activity (Figure 13). This increase in yCD PCA activity was confirmed by a survival
assay on solid medium (Figure 14).
We tested the overlapping a2 helices yCD PCA using Ras and RBD as interacting
protein partners. We found that the activity of the overlapping a2 helices yCD PCA is
dependent on the interaction of Ras and RBD. The combination of Ras-[F1]yCD and Zip
[F2]yCD PCA (Figure 13 h) showed no yCD PCA activity. Ceils were resistant to 5-FC
similarly to the mock control (Figure 13 f). This could imply that the overlapping yCD
PCA signal was observed due to the specific interaction induced by the interaction Ras and
RBD rather than yCD fragments complementing by themselves. This characteristic of yCD
PCA allows it to be considered for the development of an inhibitor screening system.
However, some colonies were observed on the plate containing 1000 tg/ml of 5-FC
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(Figure 13 g) for Ras-[Fi]yCD and RBD-[F2]yCD whereas no colonies were observed for
Zip-[F1ÏyCD and Zip-[F2]yCD PCA (Figure 13 c) under the same selection condition.
This was probably due to the fact that the recombinant proteins Ras-[F1]yCD cut4 and
RBD-[F2]yCD cuti were flot as stable as Zip-[F1]yCD cut4 and Zip-[F2]yCD cuti
recombinant proteins when expressed in budding yeast. Some of the Ras-[F1]yCD
recombinant protein was observed to be degraded by Western Blot analysis using
antibodies [c-H-ras (Ab-1) purchased from Caibiochemi specific against Ras.
4.5 yCD PCA in Mammalian Celi Lines
yCD PCA can be applied to many mammalian cell systems as a positive or negative
selection method since there is no endogenous cytosine deaminase enzyme in higher
eukaryotes. For the positive selection assay, PALA, an inhibitor of aspartate carbarnyl
transferase (CADases), must be added in order to inhibit the de novo pyrimidine synthesis
and allow the yCD to become the essential regulatory enzyme for cell survivai (Wei and
Huber 1996). In the negative selection assay, the introduction of a trans-gene system with
yCD PCA that could specifically deaminate 5-FC to 5-FU, serves as a strategy to
specificaily kiil a population of ceils. Cells carrying empty vectors have a low level of
sensitivity to high concentration of 5-FC.
In this work, our goal vas also to show an application of yCD PCA in mammalian
ceil systems. We took advantage of the death assay in order to increase specificity for
killing cancer cells. Many studies used the promoter sequences of genes that are over
expressed in cancer ceils to drive the expression of a toxic gene such as yCD or HSV1-TK.
Here, we proposed to increase the specificity for targeting cancer cells by using yCD PCA
with fragments expressed under the control of different over-expressed genes. The use of
two tumor marker promoters and yCD PCA would allow a better specificity in killing
tumor ceils and decrease the elimination of normal ceils which sometimes express one of
the tumor marker genes.
We found that the yCD PCA was most effective with individual fragments
contained the overlapping a2-helices. When two different tissue specific promoters drove
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expression of the two complementary fragments, we could inhibit the growth of HEK 293
ceils by approximately 30.5% when treated with 1000 tg/m1 5-FC. Celis carrying WinA
[F1]yCD cut 4 or WinB-[f2]yCD cuti alone were less sensitive to 1000 ig/m1 5-FC than
ceils carrying the yCD PCA. Interestingly, our data also suggest that ceils carrying WinA
[F1]yCD cut4 alone, under the control of the CMV promoter, were less sensitive to 5-FC
than celis carrying empty vectors. This effect vas observed for celis carrying WinA
[F1]yCD cut4 alone under the control of the CEA promoter as well but at a less pronounced
level. Perhaps, high level expression of WinA-{Fi]yCD cut4, when driven by the CMV
promoter, influences celis to become less sensitive to 5-FC. However, how this occurs is
not obvious. This experiment should be repeated in order to confirm that the observation is
not an artifact. In addition, we do not know if WinA, [F i]yCD cut4, or the combined
WinA-[F1]yCD cut4 fusion protein is responsible for making ceils less sensitive to 5-FC.
We could narrow down the possibility by transfecting celis with Zip-[F1]yCD cut4 and
determining if this effect can stili be observed.
We tested for the expression of the recombinant proteins in stably transfected HEK
293 ceils by western blot analysis, using a polyclonal antibody against yCD (purchased
from Biogenesis). We found that WinA-[f1]yCD cut4, WinB-[F2IyCD cuti, and WinA
yCD were detected when expressed under the control of CMV promoter, but flot detected
when expressed under the control of CEA or hTERT promoter (data flot shown). Since we
were unable to detect yCD activity in the latter stably transfected celis (Figure 16), it is
possible that WinA-[F1]yCD cut4, WinB-[F2]yCD cuti, and WinA-yCD were expressed,
but at a low levei, beyond the capacity of detection of this antibody. Interestingly, the
expression of yCD under CEA promoter lias previously been reported using another
antibody against yCD (Nyati, Sreekumar et al. 2002). Perhaps the antibody used by Nyati
et al. lias a higher affinity for yCD. We would like to try this antibody on our stably
transfected celis in order to confirm that they expressed the recombinant protein (s).
However, it is also possible that the fusion proteins, WinA-[Fi]yCD cut4, WinB-[F2]yCD
cuti, and WinA-yCD, are less stable than the wild type yCD and therefore, harder to detect
using antibody against yCD.
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In general, our findings suggest the possibility of using yCD PCA for targeting a
population of mammalian ceils for death. However, at this stage, the yCD PCA is not
efficient for inhibiting ceil growth since a high concentration of 5-FC must be used in order
to obtain an increased of 10 to 15 ¾ growth inhibition in comparison to the mock celis.
We attempted the death assay for yCD PCA in mammalian ceils using 100 ig/m1 5-FC.
Unfortunately, no significant growth inhibition was observed (data not shown).
4.6 Conclusions
We have developed the first Binary Positive and Negative PCA using yCD, which
can be used to increase the specificity of a survival selection assay or a cell growth
inhibition assay. In addition, the Binary Positive and Negative PCA can be used as a
screening tool for interacting protein partners. We chose to establish the assay in yeast and
observed the highest yCD PCA activity in the survival and death selection assay using yCD
fragments with 20 overlapping amino acid residues located on the second aipha-helix of the
enzyme. We applied yCD PCA under CMV and tissue specific promoters in mammalian
celis and found that ceil growth inhibition vas slightly inhibited using high concentration
of 5-FC.
4.7 Perspectives
At present, we are in the process of generating and testing yCD PCA activity in
CaCo-2 stable ceil lines. Based on results obtained from our promoter re-characterization
assay (figure 15), the promoter activity of CEA and hTERT promoters were similar for
HEK 293 and CaCo-2 celis. Therefore we suspect that yCD PCA activity in CaCo-2 stable
celi lines might be similar to that observed in the HEK 293 stable celi unes based on
expression levels.
For future projects, further optimization of yCD PCA to increase the 5-FC
deamination activity is required in order to apply this PCA in mammalian celis. Although
some yCD PCA activity was observed in mammalian cells when high concentration of 5-
FC was added, the activity of yCD PCA was weaker than the full-length enzyme. A
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library of yCD fragment Ï and fragment 2 can be generated by using DNA shuffling or
error-prone PCR strategy. The selection of a functional yCD PCA from the iibrary
generated fragments shouid be easy to achieve since the survival selection assay of yCD
PCA can be used. The new yCD PCAs can then be screened for an increase in 5-FC
deamination activity using the death assay.
Once the engineered yCD PCA with an improved 5-FC deamination activity is well
characterized, it can be used for applications in mammalian ceils. The engineered yCD
PCA can be used in combination with tissue specific promoters to specifically kiil a
population of celis. The engineered yCD PCA can also be used to select for a specific
clonai population of ceils with the survival assay.
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